Products

What will AGI do for Acetohexamide?

This classification denotes an anti-diabetic agent with the molecular formula C15H20N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) QGC8W08I6I, chemically known as urea, 1-((p-acetylphenyl)sulfonyl)-3-cyclohexyl- but more generally known as acetohexamide, which bears US NIH Compound Identifier 1989. European Medicines Agency schedules Acetohexamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05223MIG. The term ACETOHEXAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5) WHO schedules acetohexamide in its Anatomical Therapeutic Chemical (ATC) Classification. ACETOHEXAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule acetohexamide under HS 29350090 and SITC 51580. As of Q4 2014, ACETOHEXAMIDE remains US FDA's Preferred Term for this commodity. Acetohexamide bears US NLM identifiers UMLS ID C0733364 and NCI Concept Code C47380. SMILES: S(=O)(=O)(NC(=O)NC1CCCCC1)C1CCC(CC1)C(=O)C.